. Percentages of cyclin B-positive (CycB + ) and histone H3 pSer10-positive (H3 pS10 + ) cells were quantified. e, Clonogenic cell survival assays were carried out on 293 cells and GEN1 -/cells treated with control siRNA or siRNA against MUS81. Complementation via the stable expression of GEN1-3× FLAG is indicated. The survival of control siRNA-treated 293 cells is defined as 100%. f, Clonogenic cell survival assays were carried out on 293 cells and GEN1 -/cells treated with control siRNA or siRNA against MUS81 and the indicated concentrations of cisplatin (Cis-Pt). g, Chromosome segmentation in a metaphase spread from GEN1 -/cells treated with siRNA against MUS81 and a brief (1 h) cisplatin treatment and then released into fresh media for 24 h. h, GEN1 -/cells and 293 cells were treated as in g but released into fresh media for 24 h (red) or 48 h (blue). A total of 75 metaphase spreads per condition were analysed for chromosome (chr.) segmentation. i, GEN1 -/-(− ) and GEN1 -/cells expressing GEN1, RusA WT -GEN1 or RusA D70N -GEN1 as indicated were treated as in g. A total of 60 metaphase spreads per condition were analysed for chromosome segmentation. In b and g, representative data from three independent experiments are shown. Quantified data in c-f, h and i represent the mean ± s.d. of n = 3 independent experiments. Source data are available in Supplementary Table 1 . P values were determined using a two-tailed t-test.
treated with antibodies against cyclin B (a G2 marker) and histone H3 pSer10 (a mitotic marker), and analysed by fluorescenceactivated cell sorting (FACS) (Fig. 1d ). A significant increase in cyclin B-positive cells, but not histone H3 pSer10-positive cells, was observed. G2 arrest occurred 96 h after MUS81 siRNA treatment of the GEN1 -/cells ( Supplementary Fig. 1b ), indicating the accumulation of endogenous DNA damage. Furthermore, clonogenic assays showed massive synthetic lethality (< 10% cell survival) ( Fig. 1e ). Loss of viability and G2 arrest were rescued through the exogenous expression of FLAG-tagged GEN1 ( Fig. 1e and Supplementary  Fig. 1c,d) . The resolvase-deficient cells were highly sensitive to the DNA-damaging agents cisplatin and camptothecin ( Fig. 1f and Supplementary Fig. 1e ), but only mildly sensitive to aphidicolininduced replication stress ( Supplementary Fig. 1f ). These results are consistent with those demonstrating the involvement of MUS81-EME1 and GEN1 in the resolution of DNA repair intermediates.
To gain further insights into the interplay between GEN1 and components of the SMX complex (in particular MUS81-EME1 and SLX1-SLX4), MUS81 -/and SLX1 -/knockout cells were generated using CRISPR/Cas9 technology ( Supplementary Fig. 1g -i). Depletion of GEN1 from MUS81 -/cells induced massive cell death and severe G2 arrest ( Supplementary Fig. 2a,b ), whereas a less significant effect was seen in GEN1-depleted SLX1 -/cells. This result indicates that SLX1 may only be required for the resolution of a subset of repair intermediates. Consistent with this notion, G2 arrest and lethality was further exacerbated when both SLX1 and MUS81 were depleted in GEN1 -/cells ( Supplementary Fig. 2c,d) .
The interaction between MUS81 and the SLX4 scaffold protein is crucial for resolution events mediated by SMX 27, 30, 31, 35 . We therefore mutated the key conserved residues in SLX4 (E1577A and L1578A) that are equivalent to those previously identified in mouse SLX4 and shown to abolish MUS81-SLX4 interactions 30 ( Supplementary Fig. 2e ). We observed that depletion of GEN1 in SLX4 E1577A L1578A (SLX4 ELAA ) cells induced cell death and cell cycle arrest ( Supplementary Fig. 2f -h). These results confirm the synthetic relationship between GEN1 and SMX complex.
Unresolved recombination intermediates form UFBs.
To investigate the consequences of mitosis in cells with unresolved recombination intermediates, we briefly treated resolvase-deficient cells with cisplatin and prepared metaphase spreads 24 h later. We observed tightly associated sister chromatids that exhibited a segmented appearance ( Fig. 1g,h ). This unusual morphology was previously attributed to defects in chromosome condensation at sites of sister chromatid entanglements 17, 29, 31 . Increased levels of chromosome segmentation were observed in the resolvase-deficient cells even in the absence of exogenous damage ( Supplementary  Fig. 3a ). Segmentation was suppressed in cells expressing the bacterial resolvase RusA fused to catalytic-dead GEN1 (with E134A and E136A mutations) to ensure correct cellular regulation, but not in cells expressing catalytic-dead RusA D70N -GEN1 ( Fig. 1i and Supplementary Fig. 3b ,c). Indeed, RusA WT -GEN1 rescued all other phenotypes associated with resolvase deficiency, namely reduced SCE formation ( Supplementary Fig. 3d ) and G2 arrest ( Supplementary Fig. 3e ). These results show that the uncondensed regions arise from unresolved intermediates that interlink sister chromatids.
As unresolved recombination intermediates do not trigger the cell cycle checkpoint response, the sister chromatid linkages persist to anaphase. Consequently, ~80% of the resolvase-deficient cells (undamaged or cisplatin-treated) displayed RPA-decorated UFBs at anaphase/telophase compared with ~10-15% in control and single resolvase-depleted cells ( Fig. 2a,b and Supplementary Fig. 3f -h). The binding of RPA indicates that the bridges contain single-stranded DNA (ssDNA). Mild replication stress (for example, exposure to low-dose aphidicolin) has been shown to lead to unresolved replication intermediates at CFSs. These unresolved replication intermediates give rise to FS-UFBs exhibiting RPA and BLM staining, and with twin FANCD2 foci at their termini 5, 10, 11 . In contrast to FS-UFBs, we observed UFBs that were not flanked by FANCD2; ~5% of mock-depleted wild-type cells and ~70% of the resolvasedeficient cells displayed FANCD2-negative UFBs (Fig. 2a,b and Supplementary Fig. 3f -h). These UFBs therefore appear to represent a distinct class of UFB, which we term HR-UFBs.
To determine whether the UFBs that arise in resolvase-deficient 293 cells were representative of those in all cell types, GEN1 and MUS81 were depleted from the non-transformed diploid cell line hTERT-RPE1. Again, we observed an increase in FANCD2negative UFBs compared with control and single-resolvase depleted cells (Fig. 2g,h and Supplementary Fig. 3i ). These HR-UFBs did not associate with centromeres, as detected by CREST staining ( Supplementary Fig. 3j ).
In addition to RPA, the UFBs were also decorated with BLM ( Supplementary Fig. 4a,b ). To confirm that the RPA-and BLMcoated UFBs did not associate with FANCD2 foci or centromeres, we co-stained for RPA and BLM and either FANCD2 or CREST using U2OS cells depleted of MUS81 and GEN1 ( Supplementary  Fig. 4a ,b). We again observed that the majority of the RPA-and BLM-coated UFBs did not associate with FANCD2 (41 out of 49 UFBs were FANCD2 negative; 20 cells counted) or centromeres (34 out of 47 UFBs failed to show any association with CREST; 20 cells counted).
To provide further support for the distinction between HR-UFBs and FS-UFBs, we investigated whether FANCD2 twin foci and DNA synthesis (as indicated by EdU incorporation) 12, 13, 36 , occur at prometaphase in the resolvase-deficient cells. As expected, control cells treated with aphidicolin exhibited an increased frequency of FANCD2 twin foci and EdU foci on their mitotic chromosomes ( Fig. 2c,d and Supplementary Fig. 4c,d ), whereas brief cisplatin treatment of the resolvase-deficient cells did not lead to detectable replication stress (as indicated by FANCD2 analysis and EdU staining). Moreover, DNA fibre analysis indicated that untreated resolvase-deficient cells did not show reduced replication progression ( Fig. 2e ,f), confirming that the HR-UFBs are not induced by replication stress.
To extend our analysis of HR-UFBs, we compared resolvasedeficient cells treated with aphidicolin, or camptothecin which causes replication fork collapse and double-strand break formation ( Fig. 3a,b and Supplementary Fig. 4e ,f). Aphidicolin treatment increased the number of FANCD2-positive UFBs whereas the number of FANCD2-negative HR-UFBs remained unchanged. In contrast, camptothecin treatment induced both types of UFBs, indicating that collapsed forks and double-strand breaks lead to the formation of recombination intermediates that require processing.
To confirm that the UFBs described here are generated by homologous recombination, we depleted RAD51 or BRCA2 ( Supplementary Fig. 4g ). As inactivation of RAD51 or BRCA2 can also induce replication stress 10,37 , FANCD2-positive and FANCD2-negative UFBs were quantified. Depletion of RAD51 or BRCA2 reduced the number of FANCD2-negative UFBs (that is, HR-UFBs) and increased the number of FANCD2-positive UFBs (Fig. 3c,d ). Expression of RusA WT -GEN1, but not RusA D70N -GEN1, reduced UFB formation in the resolvase-deficient cells (Fig. 3e ,f and Supplementary Fig. 4h ,i), further supporting the concept that these UFBs are generated by homologous recombination.
HR-UFB breakage promotes DNA damage and chromosome abnormalities. As UFBs were not observed in resolvase-deficient cells that had completed cytokinesis ( Supplementary Fig. 5a ), we reasoned that the single-stranded HR-UFBs are likely to be fragile and could be broken by the spindle forces present at mitosis. We therefore determined the levels of DNA damage in the subsequent Supplementary Table 1 . P values were determined using a two-tailed t-test. Scale bars, 10 μ m.
G1 phase (cyclin A-negative cells) by visualizing MDC1 foci ( Fig. 4a,b ). The number of MDC1 foci was significantly increased 38, 39 , and DNA damage was dependent on cell division. That is, treatment with nocodazole and the MPS1 inhibitor reversine, which inhibit spindle assembly and the mitotic checkpoint respectively, rescued the increased number of MDC1 foci ( Fig. 4a,b ). We also detected increased levels of cell division-dependent DNA breaks in the resolvase-deficient cells using alkaline comet assays ( Supplementary Fig. 5b,c) . In contrast, aphidicolin-induced G1 MDC1 foci were not affected by nocodazole and reversine treatment ( Supplementary Fig. 5d ,e), consistent with previous studies showing that replication stress-induced G1 lesions are transmitted from early mitosis to daughter cells rather than being generated by cell division 38 .
To determine whether DNA damage, generated by breakage of the RPA-coated bridges, leads to cell cycle arrest ( Fig. 1b ), BrdU-pulse chase experiments were performed. Cells were briefly exposed to cisplatin for 1 h and the cells analysed for their DNA content 12-48 h after release (Fig. 4c ). The resolvase-deficient cells displayed G2 arrest only in the second cell cycle (that is, 48 h after cisplatin release). These results contrast with those obtained after depletion of ERCC1, which is involved in the early stages of interstrand crosslink (ICL) unhooking 40, 41 , as ERCC1-depleted cells show pronounced G2 arrest 24 h after cisplatin release (that is, in the first cell cycle) ( Supplementary Fig. 5f ,g). Moreover, resolvase-deficient cells showed high levels of γ H2AX, and phosphorylation of the ATM targets CHK2 T68 and KAP-1 S842, 48 h after drug release, correlating with the G2/M transition block 
UFBs with FANCD2 foci UFBs without FANCD2 foci Supplementary Table 1 . P values were determined using a two-tailed t-test. Scale bars, 10 μ m.
( Supplementary Fig. 5h ). CHK1 pS317 phosphorylation in response to ATR activation was not observed, indicating that cell cycle arrest was induced by DNA breaks rather than by replication checkpoint activation. Furthermore, inhibition of cell division by nocodazole and reversine treatment, which generated tetraploid cells with 8N DNA content, prevented activation of the DNA damage response, as measured by a reduction in S10 phosphorylation of histone H3 ( Supplementary Fig. 6a-c) . These results show that HR-UFB breakage is a consequence of cell division, leading to DNA damage in the subsequent cell cycle. Supplementary Table 1 . P values were determined using a two-tailed t-test Analysis of metaphase spreads from control and resolvasedeficient cells (24 or 48 h after release from cisplatin treatment) revealed that resolvase-deficient cells exhibited an increased frequency of chromosome fusions (end-to-end fusions and radial chromosomes) after approximately two cell cycles (Fig. 4d,e ). Inhibition of non-homologous end joining (NHEJ) by NU7026, a DNA-dependent protein kinase catalytic subunit inhibitor, suppressed this fusion phenotype (Fig. 4f ). Blocking cell division by nocodazole and reversine treatment also partially rescued the increased frequency of chromosome fusions (Fig. 4g ). Low levels of fusions also occurred in untreated resolvase-deficient cells ( Supplementary Fig. 6d ).
Resolvase-deficient cells also displayed an increased frequency of mis-segregation events compared with control cells ( Supplementary  Fig. 6e,f) . Twenty-four hours after release from cisplatin, before chromosome fusions were prominent (Fig. 4e ), most DAPI-positive anaphase bridges in the resolvase-deficient cells did not contain centromeres, indicating that they were induced by pre-mitotic defects 42 . After 48 h, the resolvase-deficient cells displayed an increased frequency of lagging chromosomes with centromeres, which correlates with chromosome fusions (Fig. 4d,e ). Inhibition of NHEJ by NU7026 partially rescued the increased frequency of lagging chromosomes with centromeres ( Supplementary Fig. 6g ). These results show that HR-UFB breakage leads to gross chromosome abnormalities mediated through NHEJ-mediated chromosome fusions.
PICH and BLM promote ssDNA formation at UFBs. To understand how RPA-coated UFBs are generated from unresolved recombination intermediates, the bridges were stained using antibodies against BLM or PICH, a protein required for the recruitment of BLM 3,4,43 and RPA2 ( Fig. 5a-d) . In early anaphase, most UFBs were coated with RPA, PICH and BLM. However, in late anaphase and early telophase, some UFBs were coated only with RPA. The UFBs were exclusively RPA2-coated at late telophase, indicating that that duplex DNA bridges are converted to ssDNA, and that PICH and BLM play a role in their processing.
To determine how single-stranded HR-UFBs arise, resolvase-deficient cells were depleted of various DNA nucleases (TREX1, MRE11, CTIP, DNA2 or EXO1) or helicases (BLM, WRN, RECQ1, RECQ4, RECQ5 or RTEL1) and then analysed for RPA-positive UFB formation. Remarkably, only BLM depletion led to significantly fewer RPApositive UFBs (Fig. 5e-g and Supplementary Fig. 7a,b) . We therefore generated cell lines expressing either GFP-tagged wild-type or catalyticdead (BLM K695M ) versions of BLM, and treated them with siRNAs against BLM (targeting the 3 ′ UTR of BLM mRNA), GEN1 and MUS81 ( Supplementary Fig. 7c ). The GFP-BLM K695M -expressing cells exhibited a significantly reduced frequency of RPA-positive UFBs compared with those expressing GFP-BLM WT (Fig. 6a,b) . Moreover, those expressing GFP-BLM K695M showed an increased percentage of cells with UFBs that were persistently coated with BLM.
Consistent with a role for BLM in the processing of HR-UFBs, an increased frequency of PICH-positive UFBs was observed when resolvase-deficient cells were depleted of BLM (Fig. 6c,d) . We therefore sought to knockout PICH to specifically investigate the mitotic functions of BLM because PICH does not play a part in the interphase actions of BLM during DNA replication and repair 8, 43 . However, we were unable to produce a complete PICH knockout in the GEN1 -/-293 cell line. We therefore targeted three out of the four alleles of PICH (this cell line is referred to as GEN1 -/-PICH 3/4 ), which resulted in reduced PICH expression ( Supplementary  Fig. 7d,e ) and slow growth compared with GEN1 -/cells (doubling time of 30 h versus 22 h; Supplementary Fig. 7f ). The resolvasedeficient PICH 3/4 cells exhibited a significantly lower frequency of RPA-positive UFBs (Fig. 6e) , supporting the hypothesis that PICH recruits BLM to unwind duplex DNA present in the HR-UFBs to generate the ssDNA bridges.
An inability to convert double-stranded bridges into fragile single-stranded UFBs might be expected to lead to cytokinesis failure. We therefore analysed the DNA content of resolvase-deficient PICH 3/4 cells (Fig. 6f,g) . We observed a significant increase in their tetraploid (8N) population compared with PICH-proficient cells, similar to previous reports showing that PICH -/-DT40 cells display increased polyploidy 8 . These results indicate that PICH and BLM generate the single-stranded bridges that facilitate cell division.
A general mechanism for UFB processing. As HR-UFBs and replication stress-induced FS-UFBs both exhibit RPA binding ( Figs. 2a  and 3a) , we next determined whether ssDNA formation represents a common mechanism of UFB processing. Generation of catenanedependent centromeric UFBs using the topoisomerase II inhibitor ICRF-193 ( Fig. 7a-d ) induced the conversion of many centromeric UFBs to ssDNA. There was a clear reduction in the number of RPAcoated centromeric UFBs following depletion of BLM (Fig. 7a,b ) or in PICH 3/4 cells (Fig. 7c,d) , as observed previously 44 . These results indicate that HR-UFBs, FS-UFBs and C-UFBs are processed by a common mechanism involving ssDNA formation and RPA binding to facilitate their subsequent breakage and repair.
Discussion
In this work, we described the generation of a resolvase-deficient model that can be used to follow the biological fate of unresolved recombination intermediates at mitosis. Homologous recombination intermediates fail to elicit a checkpoint response and therefore persist until mitosis and give rise to a distinct class of UFBs. PICH and BLM act on the interlinked sister chromatids, which are converted to RPA-coated ssDNA bridges. These HR-UFBs are distinct from replication stress-induced UFBs that are characteristically flanked by FANCD2 foci. However, our data indicate that HR-UFBs, FS-UFBs and C-UFBs all share some common aspects of processing that are necessary for their breakage and result in chromosome segregation and cell division. Disruption of ssDNA formation, via inactivation of the BLM helicase, leads to cytokinesis failure.
Breaking chromosomal DNA requires up to ~100 nN force 45 , which is ~100 times greater than the spindle forces generated by kinetochore fibres (~1 nN) 46 . However, the force required to break a single covalent bond is 1-2 nN 47, 48 , making it plausible that singlestranded bridges may be sheared by the tensile forces generated by the spindle during mitosis. In contrast to the single-stranded UFBs visualized here at anaphase/telophase, dicentric or lagging chromosomes induce cleavage furrow regression 49, 50 or become stabilized as chromatin bridges between daughter cells, and persist for several hours until ssDNA become apparent and breakage occurs 15, 50 . Figure 7e shows a schematic for HR-UFB processing. PICH recruits BLM helicase to HR-UFBs so that BLM can unwind the duplex DNA into single strands that are subsequently broken to permit cell division. Our work shows that HR-UFBs, FS-UFBs and C-UFBs all become decorated with RPA, a process dependent on PICH and BLM, indicating that DNA unwinding by BLM provides a universal mechanism that facilitates bridge resolution or breakage. Whether the initial duplex bridge needs to be nicked to allow access by PICH and BLM, or whether the tensile force of the spindle generates sufficient force to overstretch and melt the DNA to allow binding by PICH and BLM binding, is currently unknown.
Bridge processing reduces the risk of cytokinesis failure. However, this process may occur at the expense of DNA damage and the potential for chromosomal aberrations in the subsequent cell cycle. Indeed, in our resolvase-deficient system, we observed high levels of NHEJ-dependent end-to-end chromosome fusions and radial chromosomes, together with an increased frequency of mis-segregation. As the fusions were not observed when cell division was blocked by nocodazole and reversine treatment, they appear to be products of breakage that occurred in the previous mitosis. The breakage and reunion events observed here are consistent with previous studies showing that NHEJ promotes chromosome abnormalities such as translocations and chromothripsis following a defective mitosis 51, 52 .
Chromosomal instability (CIN) is a common trait of cancer cells. Cellular defects such as replication stress, merotelic kinetochore attachment and impairment of the cohesion network are Supplementary Table 1 . P values were determined using a two-tailed t-test, *P = 4 × 10 −5 , **P < 0.002. Scale bars, 10 µ m.
known to drive CIN 42, 53, 54 . Our findings reveal that unresolved recombination intermediates may also serve as a potential driver of CIN. Although resolvase deficiency has not yet been described in any cancer model, and our model system provides an extreme demonstration of the fate of multiple unresolved recombination intermediates, our results demonstrate the fate of any homologous Supplementary Table 1 . P values were determined using a two-tailed t-test. Scale bars, 10 µ m. recombination intermediates that escape detection by the dissolution and resolution pathways. These findings may be particularly pertinent to cancer cells in which the homologous recombination pathway is hyper-activated and the load of recombination intermediates is increased (for example, when RAD51 activity is increased) [55] [56] [57] . Finally, the synthetic lethal relationship observed between MUS81 and SLX4 and GEN1 indicates that resolvases might represent plausible targets for cancer therapies, possibly in combination with DNA-damaging agents such as cisplatin. It may therefore be interesting to determine whether tumours that confer resistance to DNA-damaging agents due to enhanced homologous recombination-mediated repair show a selective sensitivity to resolvase inhibition compared with normal cells.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-017-0011-1. Supplementary Table 1 . P values were determined using a two-tailed t-test. Scale bars, 10 µ m.
Fluor 488 secondary antibody (Thermo Fisher) for 30 min. For the detection of cyclin B1, cells were fixed with 2% paraformaldehyde in PBS for 10 min followed by cold 70% ethanol overnight. Fixed cells were washed twice in PBS and once in PBS-T. The cells were then treated with mouse anti-cyclin B (Cell Signaling 4135) for 30 min at room temperature, washed twice and stained with anti-mouse Alexa Fluor 488 secondary antibody (Thermo Fisher) for 30 min. Following antibody staining, the cells were washed with PBS and stained with either propidium iodide (for ethanol-fixed cells) or 0.5 µ g ml -1 DAPI (for paraformaldehyde-fixed cells). Samples were analysed using a FACSCalibur or a LSRFortessa Analyzer (BD Biosciences), and at least 10,000 events were acquired per sample. FACS data were analysed using FlowJo software. Cell doublets and debris were excluded from analysis. Cell cycle population analysis was performed using the Watson pragmatic algorithm with FlowJo software.
Comet assays. Alkaline comet assays were performed using a CometAssay kit from Amsbio (4250-050-K) according to the manufacturer's protocol. Alkaline electrophoresis was performed in a BioRad Mini-Sub Cell GT system (20 volts, 250-300 mA for 30 min), and the comets were stained with SYBR Gold staining solution (Thermo Fisher, 1:10,000 in TE buffer). The percentage of DNA in the tail was measured using ImageJ software with the Comet Assay plugin (https://www. med.unc.edu/microscopy/resources/imagej-plugins-and-macros/comet-assay).
siRNA. The control siRNA (5′ -UAAUGUAUUGGAACGCAUA-3′ ), BLM siRNA (5′ -CCGAAUCUCAAUGUACAUAGA-3′ ) 62 , RECQ5 siRNA (5′ -CAGGAGGCUGAUAAAGGGUUA-3′ ) 62 , TREX1 siRNA (5′ -CCAAGACCAUCUGCUGUCA-3′ ) 63 , CTIP siRNA (5′ -GCUAAAACAGGAACGAAUC-3′ ) 64 , GEN1 siRNA (5′ -GUAAAGACCUGCAAUGUUA-3′ ) were purchased from Eurofins. The MUS81 siRNA (5′ -CAGCCCUGGUGGAUCGAUA-3′ and 5′ -CAUUAAGUGUGGGCGUCUA-3′ ) 29 , SLX1 siRNA (5′ -UGGACAGACCUGCUGGAGAUU-3′ ) 22 Metaphase spreads. To analyse chromosome aberrations, cells were treated with siRNA 24 h before a brief cisplatin treatment (1 µ g ml -1 for 1 h) and then released into fresh media for 24 or 48 h. Cells were then treated with colcemid (0.2 μ g ml -1 ) for 1 h before being collected, and metaphase chromosomes were prepared as previously described 29 . Segmented chromosomes were scored as those containing two or more indentations per chromosome. For sister chromatid exchange analyses, cells were treated with BrdU (100 µ M) for 48 h, and colcemid (0.2 µ g ml -1 ) was added 1 h before collection. The SCE assay was performed as previously described 29 .
DNA fibre assays. DNA fibre assays were carried out essentially as previously described 65 . In brief, 293 cells were pulsed with 15 µ M CldU (Sigma-Aldrich) for 20 min, washed once with media and labelled with 200 µ M IdU (Sigma-Aldrich) for 40 min. Cells were trypsinized, resuspended in PBS and placed on ice. Cells were counted, their concentration adjusted to 500,000 cells per ml, and then mixed 1:5 with unlabelled cells. A total of 3 µ L of the cell suspension was placed on top of a glass slide (Superfrost, 90° edges) followed by addition of 9 μ L lysis buffer (0.5% SDS, 200 mM Tris-HCl pH 7.4, 50 mM EDTA) and lysed by moving a pipette in a circular motion until the liquid became viscous. The slides were left for 2 min before tilting them at a 10-15° angle to allow the viscous cell lysate to run slowly downwards. The slides were fixed in a methanol:acetic acid solution (3:1) for 15 min at room temperature and air dried before staining. The DNA fibres were denatured by incubating the slides in 2.5 M HCl solution for 60 min. The slides were then washed twice in PBS and blocked in PBS supplemented with 1% BSA for 30 min at room temperature. Slides were stained with rat anti-BrdU (1:1200 dilution; Serotec, BU1/75, OBT0030CX;) and mouse anti-BrdU (1:500 dilution; BD Biosciences, B44) in PBS containing 1% BSA for 2 h, and washed twice in PBS before staining with anti-rat Alexa 594 and anti-mouse Alexa 488 (both 1:500 dilutions; Thermo Fisher) in PBS containing BSA for 1 h. Slides were washed twice in PBS followed by one wash in deionized H 2 O and left to air dry in the dark. The slides were mounted with Prolong Gold antifade mountant (Thermo Fisher) and images were acquired on a Zeiss AXIO Imager M2 microscope equipped with a plan-SPOCHROMAT 63 × 1.4 oil objective (Zeiss) using Volocity software. Images were analysed using ImageJ software.
Statistics and reproducibility.
Experiments were not randomized and no blinding was used during data analyses. No statistical methods were used to predetermine sample sizes. Sample sizes were determined based on previous experience to obtain statistical significance and reproducibility. All error bars represent mean ± standard deviation (s.d.) of three independent experiments. Statistical testing was performed using the two-tailed t-test. A P value of 0.05 was considered as borderline for statistical significance. Each experiment was repeated at least three times, with the exception of the those presented in Supplementary Fig. 2g ,h (two experiments performed) and Fig. 4c , Supplementary Figs. 1b,d, 2b-d Corresponding author(s): Stephen C. West
Initial submission Revised version Final submission
Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to predetermine sample size. Sample sizes were determined based on previous experience to obtain statistical significance and reproducibility.
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All experimental findings were reliably reproduced in multiple independent experiments.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
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